je.st
news
FDA approves Novo Nordisk's weight loss injection, Saxenda
2014-12-26 06:37:52| Biotech - Topix.net
Novo Nordisk today announced that the Food and Drug Administration has approved the new drug application for Saxenda , the first once-daily glucagon-like peptide-1 receptor agonist for chronic weight management. Saxenda is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity or who are overweight in the presence of at least one weight-related comorbid condition.
Tags: loss
weight
novo
injection
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|